BriaCell Therapeutics Stock Forecast

BCTX's stock price has decreased by -91.57% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 1 analyst with a 12-month price forecast for BriaCell Therapeutics stock has a target of 32, which predicts an increase of 786.43% from the current stock price of 3.61.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$32	$32	$32	$32
Change	+786.43%	+786.43%	+786.43%	+786.43%

* Price targets were last updated on Feb 3, 2025.

Analyst Ratings

According to 1 stock analyst, the rating for BriaCell Therapeutics is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25
Strong Buy	1	1	1	1	1	1
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	1	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Emily Bodnar HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $15 → $32	Strong Buy	Maintains	$15 → $32	+786.43%	Feb 3, 2025
Emily Bodnar HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $225	Strong Buy	Reiterates	$225	+6,132.69%	Dec 12, 2024
Emily Bodnar HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $225	Strong Buy	Reiterates	$225	+6,132.69%	Dec 3, 2024
Emily Bodnar HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $225	Strong Buy	Reiterates	$225	+6,132.69%	Oct 3, 2024
Emily Bodnar HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $270 → $225	Strong Buy	Maintains	$270 → $225	+6,132.69%	Sep 19, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-5.20

from -4.37

EPS Next Year

-1.48

from -5.20

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Jul 31, 2020	Jul 31, 2021	Jul 31, 2022	Jul 31, 2023	Jul 31, 2024	Jul 31, 2025	Jul 31, 2026	Jul 31, 2027
Revenue	-	-	10.20M
Revenue Growth	-	-	-	-	-	-	-	-
EPS	-84.56	-45.85	-25.98	-19.50	-4.37	-5.20	-1.48	-1.10
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	3	2	2

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	n/a	n/a	10.6M
Avg	n/a	n/a	10.2M
Low	n/a	n/a	9.9M

Revenue Growth

Revenue Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027
High	-2.57	-1.54	-1.14
Avg	-5.20	-1.48	-1.10
Low	-7.68	-1.44	-1.07

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.